Leveraging personalized circulating tumor DNA monitoring to predict treatment response and recurrence in high-risk endometrial cancer

被引：0

作者：

Pham, Melissa ^{[1
]}

Scalise, Carly Bess ^{[2
]}

Kalashnikova, Ekaterina ^{[2
]}

Dutta, Punashi ^{[2
]}

Chen, Xi ^{[3
]}

Narcisse, Subrina ^{[1
]}

Rangel, Kelly ^{[1
]}

Urbauer, Diana ^{[3
]}

Elnaggar, Adam ^{[2
]}

Westin, Shannon ^{[1
]}

Jazaeri, Amir ^{[1
]}

Lu, Karen ^{[1
]}

Soliman, Pamela ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX USA

[2] Natera Inc, Translat Med, Austin, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期

关键词：

D O I：

10.1136/ijgc-2023-IGCS.251

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP159

引用

页码：A141 / A141

页数：1

共 50 条

[1] Personalized monitoring of circulating tumor DNA during neoadjuvant therapy in high-risk early stage breast cancer reflects response and risk of metastatic recurrence
Magbanua, Mark Jesus M.
Brown-Swigart, Lamorna
Hirst, Gillian
Yau, Christina
Wolf, Denise
Wu, Hsin-Ta
Tin, Antony
Shchegrova, Svetlana
Sethi, Himanshu
Salari, Raheleh
Aleshin, Alexey
Louie, Maggie
Zimmermann, Bernhard
DeMichele, Angela
Liu, Minetta
Delson, Amy
Chien, Amy Jo
Asare, Smita
Esserman, Laura
van't Veer, Laura
CANCER RESEARCH, 2020, 80 (04)
[2] Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Weiwei Feng
Nan Jia
Haining Jiao
Jun Chen
Yan Chen
Yueru Zhang
Menghan Zhu
Chongying Zhu
Lifei Shen
Wenqing Long
Journal of Translational Medicine, 19
[3] Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Feng, Weiwei
Jia, Nan
Jiao, Haining
Chen, Jun
Chen, Yan
Zhang, Yueru
Zhu, Menghan
Zhu, Chongying
Shen, Lifei
Long, Wenqing
JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
[4] Leveraging personalized circulating tumor DNA (ctDNA) for detection and monitoring of molecular residual disease in high-risk melanoma.
Genta, Sofia
Araujo, Daniel Vilarim
Keshavarzi, Sareh
Muniz, Thiago Pimentel
Kamil, Zaid Saeed
Howarth, Karen
Terrell, Samantha
Joad, Andy
Ventura, Robert
Covelli, Andrea
Saibil, Samuel
Spiliopoulou, Pavlina
Vornicova, Olga
Easson, Alexandra Maria
Butler, Marcus O.
Siu, Lillian L.
Bratman, Scott Victor
Spreafico, Anna
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[5] Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
Moss, Esther L.
Gorsia, Diviya N.
Collins, Anna
Sandhu, Pavandeep
Foreman, Nalini
Gore, Anupama
Wood, Joey
Kent, Christopher
Silcock, Lee
Guttery, David S.
CANCERS, 2020, 12 (08) : 1 - 13
[6] Detection of Circulating Tumor Cells in High-risk Endometrial Cancer
Bogani, Giorgio
Liu, Minetta C.
Dowdy, Sean C.
Cliby, William A.
Kerr, Sarah E.
Kalli, Kimberly R.
Kipp, Benjamin R.
Halling, Kevin C.
Campion, Michael B.
Mariani, Andrea
ANTICANCER RESEARCH, 2015, 35 (02) : 683 - 687
[7] Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)
Abdelrahim, M.
Esmail, A.
He, A. R.
Franses, J.
Bhan, I.
Victor, D. W.
Kodali, S.
Connor, A. A.
Saharia, A.
Brdiges, C.
Tin, T.
Brewer, C.
Jurdi, A.
Liu, M. C.
Ghobrial, R. M.
ANNALS OF ONCOLOGY, 2023, 34 : S600 - S600
[8] Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk stage II-III gastrointestinal stromal tumor
Gao, Zhidong
Cheng, Baosen
Bao, Yudi
Cui, Peng
Du, Haiwei
Fan, Xuning
Peng, Di
Yang, Shuya
Wu, Xin
Zhao, Dongbing
Xing, Zhaodong
Cao, Feng
Zhang, Wei
Li, Bing
Li, Chengcheng
Zhang, Yuzi
Wang, Guoqiang
Cai, Shangli
Ye, Yingjiang
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[9] Circulating tumor DNA for personalized lung cancer monitoring
Clare Fiala
Eleftherios P. Diamandis
BMC Medicine, 15
[10] Circulating tumor DNA for personalized lung cancer monitoring
Fiala, Clare
Diamandis, Eleftherios P.
BMC MEDICINE, 2017, 15

← 1 2 3 4 5 →